Dr. Adam Sperling received his medical degree and PhD in Biological Chemistry from the University of California, Los Angeles in 2011. He completed his residency in internal medicine at the Brigham and Women's Hospital and his fellowship in Hematology and Oncology at the Dana-Farber Cancer Institute. He received board certification from the American Board of Internal Medicine in 2014, in Medical Oncology in 2017 and in Hematology in 2018.

Dr. Michael Schumacher is a gastrointestinal physiologist focused on discovering new therapeutic targets for inflammatory bowel disease (IBD) including ulcerative colitis and Crohn’s disease. Dr. Schumacher's lab studies how intestinal tissues interpret, respond to, and recover from inflammation, with a particular emphasis on how immune signals shape epithelial function, tissue remodeling, and mucosal healing.

Dr. Marissa Reitsma is an Assistant Professor of Health Policy at Stanford University School of Medicine. She obtained her PhD in Health Policy at Stanford in 2024, during which time she was a Knight-Hennessy Scholar, Stanford Data Science Scholar, and NSF Graduate Research Fellow. Previously, she worked on the Global Burden of Disease Study at the Institute for Health Metrics and Evaluation. Dr.

Dr. Kimberley Tolias is a Professor in the Department of Anesthesiology, Perioperative and Pain Medicine at Stanford University School of Medicine. The Tolias laboratory studies the molecular and cellular mechanisms that govern neural circuit formation, plasticity, and repair in the mammalian central nervous system (CNS). In particular, the lab investigates how synapses and neural circuits form, remodel, and adapt throughout life to support learning, memory, behavior, and recovery following injury.

Dr. Hyunseok “Hyu” Kang, MD, MPH is a medical oncologist specializing in head and neck cancers, including squamous cell carcinoma, salivary gland cancers, thyroid cancers, and other rare tumors. He serves as Leader of the Head and Neck Cancer Research Program at the Stanford Cancer Institute and Leader of Head and Neck Medical Oncology. His research focuses on developing clinical trials with novel therapies, including immunotherapy, targeted agents, and antibody-drug conjugates, to improve outcomes for patients with rare and aggressive head and neck cancers.

Dr. Tait Shanafelt is the chief wellness officer, associate dean, and Jeanie and Stewart Ritchie Professor of Medicine at Stanford University. Dr. Shanafelt is a hematologist/oncologist whose clinical work focuses on the care of patients with chronic lymphocytic leukemia. 

Dr. Yuyan Wang is an assistant professor of marketing and Kevin J. O’Donohue Family Faculty Scholar for 2024–2025 at Stanford Graduate School of Business. With over six years of industry experience at Google DeepMind and Uber as a machine learning researcher, she has designed algorithms for understanding and improving the long-term values of recommender systems, many of which have been deployed globally in multiple products at Google and Uber Eats.

Dr. Joonhee Choi is an Assistant Professor of Electrical Engineering at Stanford University. Joonhee received his Ph.D. and master’s from Harvard University, as well as master’s and bachelor’s degrees from Korea Advanced Institute of Science & Technology. Prior to joining Stanford, he worked as an IQIM postdoctoral fellow at the Institute for Quantum Information and Matter (IQIM) at Caltech. Joonhee’s research focus has been on engineering the dynamics of quantum many-body systems for both exploring fundamental science and demonstrating practical quantum applications.

Dr. Sharon Chinthrajah is a physician-scientist trained in Pulmonary and Critical Care Medicine and Allergy & Immunology whose research focuses on precision immunotherapies for food allergy and other immune-mediated diseases. Her work integrates clinical trials, mechanistic immunology, systems biology, and biomarker discovery to develop targeted, disease-modifying treatments.

Dr. Victor Henderson is professor of Epidemiology & Population Health and of Neurology & Neurological Sciences, with interests in neuroepidemiology and brain–behavior relations in aging and dementia. His research focuses on risk factors for cognitive aging and neurodegenerative dementia, and on interventions to help prevent and treat these disorders. He directs the NIH Stanford Alzheimer's Disease Research Center and co-directs the master’s degree program in Epidemiology & Clinical Research. He is an Honorary Skou Professor at Aarhus University in Denmark.